{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:12:45Z","timestamp":1784563965214,"version":"3.55.0"},"reference-count":54,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015326","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20-GM104420"],"award-info":[{"award-number":["P20-GM104420"]}],"id":[{"id":"10.13039\/100015326","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Idaho REEU"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The phages used to treat bacterial infections in phage therapy are commonly chosen based on their abilities to form plaques on the infecting bacterium\u2013on host range. In practice, phage therapy is not always successful, leaving room for improvement. Here, we use computational models to investigate whether some standard phage properties (burst size, lysis rate, adsorption rate constant, intrinsic decay rate, and growth rate) might serve as predictors of treatment success. As our measure of treatment success, we deviate from many other approaches by calculating the number of phages needed to suppress bacterial densities 100-fold in the short term, given that the patient\u2019s immune system is expected to regain control once bacterial numbers are reduced. Numerical analysis of single-phage trials across 2400 combinations of phage phenotypes reveals that, on average, adsorption rate constant and growth rate provide the most useful predictive values, decay rate provides some value, whereas burst size and lysis time offer essentially little or no value. Bacterial density is especially informative of the number of phages required for treatment. There is nonetheless often considerable variation around average behavior for a single phenotype. These results raise the possibility that the adsorption rate constant and growth rate may be especially important in phage therapy performance for both high and low bacterial densities. Given that therapeutic phages are often evolved in vitro for broad host ranges rather than for individual hosts, it should be considered that selection for broad host range may have a downside of compromising adsorption to and growth rate on individual bacterial hosts.<\/jats:p>","DOI":"10.3390\/v18020240","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:09:32Z","timestamp":1770998972000},"page":"240","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Modeling the Phage Properties Best for Therapy"],"prefix":"10.3390","volume":"18","author":[{"given":"James J.","family":"Bull","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, University of Idaho, Moscow, ID 83844, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurneet","family":"Kaur","sequence":"additional","affiliation":[{"name":"University of Idaho, Moscow, ID 83844, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Krone","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Statistical Science, University of Idaho, Moscow, ID 83844, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.00954-17","article-title":"Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection","volume":"61","author":"Schooley","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.addr.2018.06.018","article-title":"Use of phage therapy to treat long-standing, persistent, or chronic bacterial infections","volume":"145","author":"Abedon","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus","volume":"25","author":"Dedrick","year":"2019","journal-title":"Nat. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s41591-021-01403-9","article-title":"Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection","volume":"27","author":"Dedrick","year":"2021","journal-title":"Nat. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/cid\/ciac453","article-title":"Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease","volume":"76","author":"Dedrick","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s41030-022-00210-y","article-title":"Phage Therapy for Nontuberculous Mycobacteria: Challenges and Opportunities","volume":"9","author":"Hatfull","year":"2023","journal-title":"Pulm. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","article-title":"Personalized bacteriophage therapy outcomes for 100 consecutive cases: A multicentre, multinational, retrospective observational study","volume":"9","author":"Pirnay","year":"2024","journal-title":"Nat. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Danis-Wlodarczyk, K.M., Alves, D.R., and Abedon, S.T. (2024). Phage therapy. Handbook of Molecular Biotechnology, CRC Press. [1st ed.].","DOI":"10.1201\/9781003055211-54"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1128\/AAC.01774-15","article-title":"Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo","volume":"60","author":"Nale","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1099\/00221287-39-3-373","article-title":"Depolymerases for bacterial exopolysaccharides obtained from phage-infected bacteria","volume":"39","author":"Sutherland","year":"1965","journal-title":"J. Gen. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.virol.2009.11.040","article-title":"A tale of tails: Sialidase is key to success in a model of phage therapy against K1-capsulated Escherichia coli","volume":"398","author":"Bull","year":"2010","journal-title":"Virology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1073\/pnas.93.8.3188","article-title":"Long-circulating bacteriophage as antibacterial agents","volume":"93","author":"Merril","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Serwer, P., Wright, E.T., and Lee, J.C. (2019). High murine blood persistence of phage T3 and suggested strategy for phage therapy. BMC Res. Notes, 12.","DOI":"10.1186\/s13104-019-4597-1"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e2104592118","DOI":"10.1073\/pnas.2104592118","article-title":"Coevolutionary phage training leads to greater bacterial suppression and delays the evolution of phage resistance","volume":"118","author":"Borin","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1086\/283134","article-title":"Resource-limited growth, competition, and predation: A model and experimental studies with bacteria and bacteriophage","volume":"977","author":"Levin","year":"1977","journal-title":"Am. Nat."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Abedon, S.T. (2008). Modeling of bacteriophage therapy. Bacteriophage Ecology: Population Growth, Evolution, and Impact of Bacterial Viruses, Cambridge University Press. Advances in Molecular and Cellular Microbiology.","DOI":"10.1017\/CBO9780511541483"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3109\/1040841X.2015.1114466","article-title":"Computational models of populations of bacteria and lytic phage","volume":"42","author":"Martin","year":"2016","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7814","DOI":"10.1038\/s41467-024-51913-6","article-title":"Using bacterial population dynamics to count phages and their lysogens","volume":"15","author":"Geng","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e2513377122","DOI":"10.1073\/pnas.2513377122","article-title":"Quantifying phage infectivity from characteristics of bacterial population dynamics","volume":"122","author":"Blazanin","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"d\u2019Herelle, F. (1922). The Bacteriophage, Its R\u00f4le in Immunity, Williams & Wilkins Company.","DOI":"10.5962\/bhl.title.31194"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Adams, M.H. (1959). Bacteriophages, Interscience Publishers.","DOI":"10.5962\/bhl.title.6966"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Abedon, S.T. (2026). Broth Optical Density-Based Assessment for Phage Therapy: Turbidity Reduction, Antibacterial Virulence, and Time-Kill. Viruses, 18.","DOI":"10.3390\/v18010097"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1558-5646.1961.tb03139.x","article-title":"Conditions for the existence of bacteriophage","volume":"15","author":"Campbell","year":"1961","journal-title":"Evolution"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1128\/AAC.05842-11","article-title":"In vivo growth rates are poorly correlated with phage therapy success in a mouse infection model","volume":"56","author":"Bull","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1128\/AAC.01596-13","article-title":"Predicting in vivo efficacy of therapeutic bacteriophages used to treat pulmonary infections","volume":"57","author":"Henry","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e964081","DOI":"10.4161\/21597073.2014.964081","article-title":"Phage fitness may help predict phage therapy efficacy","volume":"4","author":"Lindberg","year":"2014","journal-title":"Bacteriophage"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00003088-200342040-00002","article-title":"Pharmacokinetic principles of bacteriophage therapy","volume":"42","author":"Payne","year":"2003","journal-title":"Clin. Pharmacokinet"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Weitz, J.S. (2016). Quantitative Viral Ecology: Dynamics of Viruses and Their Microbial Hosts, Princeton University Press.","DOI":"10.23943\/princeton\/9780691161549.001.0001"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Bull, J.J., Heineman, R.H., and Wilke, C.O. (2011). The phenotype-fitness map in experimental evolution of phages. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027796"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"veae100","DOI":"10.1093\/ve\/veae100","article-title":"Mathematical comparison of protocols for adapting a bacteriophage to a new host","volume":"10","author":"Bull","year":"2024","journal-title":"Virus Evol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"128230","DOI":"10.1016\/j.micres.2025.128230","article-title":"Bridging phage production models and practical applications to control antibiotic-resistant bacteria","volume":"298","author":"Wang","year":"2025","journal-title":"Microbiol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-60327-164-6_18","article-title":"Practical methods for determining phage growth parameters","volume":"501","author":"Hyman","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"ref_33","first-page":"2703","article-title":"Pharmacodynamics of non-replicating viruses, bacteriocins and lysins","volume":"273","author":"Bull","year":"2006","journal-title":"Proc. Biol. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1128\/AAC.47.4.1301-1307.2003","article-title":"Use of genetically engineered phage to deliver antimicrobial agents to bacteria: An alternative therapy for treatment of bacterial infections","volume":"47","author":"Westwater","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.urology.2015.04.002","article-title":"Intracellular Bacterial Communities: A Potential Etiology for Chronic Lower Urinary Tract Symptoms","volume":"86","author":"Scott","year":"2015","journal-title":"Urology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/cyto.a.23370","article-title":"FAST: Rapid Determinations of Antibiotic Susceptibility Phenotypes using Label-Free Cytometry","volume":"93","author":"Huang","year":"2018","journal-title":"Cytom. A"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1086\/285884","article-title":"Phage Therapy Revisited: The Population Biology of a Bacterial Infection and Its Treatment with Bacteriophage and Antibiotics","volume":"147","author":"Levin","year":"1996","journal-title":"Am. Nat."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrmicro822","article-title":"Population and evolutionary dynamics of phage therapy","volume":"2","author":"Levin","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jtbi.2006.01.027","article-title":"Optimality models of phage life history and parallels in disease evolution","volume":"241","author":"Bull","year":"2006","journal-title":"J. Theor. Biol."},{"key":"ref_40","first-page":"2659","article-title":"Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs","volume":"129","author":"Smith","year":"1983","journal-title":"J. Gen. Microbiol."},{"key":"ref_41","first-page":"307","article-title":"Successful treatment of experimental Escherichia Coli Infect. Mice Using Phage: Its Gen. Super. Antibiot","volume":"128","author":"Smith","year":"1982","journal-title":"J. Gen. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/jac\/dki177","article-title":"Treatment of experimental Escherichia coli infection with recombinant bacteriophage-derived capsule depolymerase","volume":"56","author":"Mushtaq","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e0165923","DOI":"10.1128\/aem.01659-23","article-title":"Efficient assays to quantify the life history traits of algal viruses","volume":"89","author":"Lievens","year":"2023","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e1096995","DOI":"10.1080\/21597081.2015.1096995","article-title":"Development of expanded host range phage active on biofilms of multi-drug resistant Pseudomonas aeruginosa","volume":"6","author":"Mapes","year":"2016","journal-title":"Bacteriophage"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Burrowes, B.H., Molineux, I.J., and Fralick, J.A. (2019). Directed in Vitro Evolution of Therapeutic Bacteriophages: The Appelmans Protocol. Viruses, 11.","DOI":"10.3390\/v11030241"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0006-3495(92)81958-6","article-title":"Replication of viruses in a growing plaque: A reaction-diffusion model","volume":"61","author":"Yin","year":"1992","journal-title":"Biophys. J."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Bull, J.J., Levin, B.R., and Molineux, I.J. (2019). Promises and pitfalls of in vivo evolution to improve phage therapy. Viruses, 11.","DOI":"10.3390\/v11121083"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Chaudhry, W.N., Concepci\u00f3n-Acevedo, J., Park, T., Andleeb, S., Bull, J.J., and Levin, B.R. (2017). Synergy and order effects of antibiotics and phages in killing Pseudomonas aeruginosa biofilms. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0168615"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Latz, S., Kr\u00fcttgen, A., H\u00e4fner, H., Buhl, E.M., Ritter, K., and Horz, H.P. (2017). Differential Effect of Newly Isolated Phages Belonging to PB1-Like, phiKZ-Like and LUZ24-Like Viruses against Multi-Drug Resistant Pseudomonas aeruginosa under Varying Growth Conditions. Viruses, 9.","DOI":"10.3390\/v9110315"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s42003-019-0633-x","article-title":"Spatial structure affects phage efficacy in infecting dual-strain biofilms of Pseudomonas aeruginosa","volume":"2","author":"Testa","year":"2019","journal-title":"Commun. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Shrestha, P., Tandukar, S., Shrestha, M., Shrestha, S., Subedee, A., Shakya, J., and Tuladhar, R. (2025). Bacteriophage as an anti-biofilm agent against Pseudomonas aeruginosa from wound infection. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0334139"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41564-017-0050-1","article-title":"Dynamic biofilm architecture confers individual and collective mechanisms of viral protection","volume":"3","author":"Vidakovic","year":"2018","journal-title":"Nat. Microbiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e00877-19","DOI":"10.1128\/msystems.00877-19","article-title":"Biofilm Structure Promotes Coexistence of Phage-Resistant and Phage-Susceptible Bacteria","volume":"5","author":"Simmons","year":"2020","journal-title":"mSystems"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"veac086","DOI":"10.1093\/ve\/veac086","article-title":"Phenotypic flux: The role of physiology in explaining the conundrum of bacterial persistence amid phage attack","volume":"8","author":"Igler","year":"2022","journal-title":"Virus Evol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/2\/240\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:13:13Z","timestamp":1770999193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/2\/240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":54,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["v18020240"],"URL":"https:\/\/doi.org\/10.3390\/v18020240","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]}}}